140 related articles for article (PubMed ID: 9426739)
21. Image guided photothermal focal therapy for localized prostate cancer: phase I trial.
Lindner U; Weersink RA; Haider MA; Gertner MR; Davidson SR; Atri M; Wilson BC; Fenster A; Trachtenberg J
J Urol; 2009 Oct; 182(4):1371-7. PubMed ID: 19683262
[TBL] [Abstract][Full Text] [Related]
22. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer.
Nakashima J; Tanimoto A; Imai Y; Mukai M; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
Urology; 2004 Jul; 64(1):101-5. PubMed ID: 15245944
[TBL] [Abstract][Full Text] [Related]
23. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
Kapustin VV
Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
[TBL] [Abstract][Full Text] [Related]
25. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?
Latchamsetty KC; Borden LS; Porter CR; Lacrampe M; Vaughan M; Lin E; Conti N; Wright JL; Corman JM
Can J Urol; 2007 Feb; 14(1):3429-34. PubMed ID: 17324322
[TBL] [Abstract][Full Text] [Related]
26. Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
Bianco FJ; Mallah KN; Korets R; Hricak H; Scardino PT; Kattan MW
Urology; 2007 Feb; 69(2):343-6. PubMed ID: 17320675
[TBL] [Abstract][Full Text] [Related]
27. [Clinical value of native and contrast enhanced MRI in staging prostatic carcinoma before planned radical prostatectomy].
Kuhn M; Huttmann P; Spielhaupter E; Gross-Fengels W; Schreiter F
Rofo; 2001 Jul; 173(7):595-600. PubMed ID: 11512230
[TBL] [Abstract][Full Text] [Related]
28. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
Zelhof B; Lowry M; Rodrigues G; Kraus S; Turnbull L
BJU Int; 2009 Sep; 104(5):621-7. PubMed ID: 19281464
[TBL] [Abstract][Full Text] [Related]
29. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate.
Woodrum DA; Gorny KR; Mynderse LA; Amrami KK; Felmlee JP; Bjarnason H; Garcia-Medina OI; McNichols RJ; Atwell TD; Callstrom MR
Urology; 2010 Jun; 75(6):1514.e1-6. PubMed ID: 20381834
[TBL] [Abstract][Full Text] [Related]
31. Construction and evaluation of an anatomically correct multi-image modality compatible phantom for prostate cancer focal ablation.
Lindner U; Lawrentschuk N; Weersink RA; Raz O; Hlasny E; Sussman MS; Davidson SR; Gertner MR; Trachtenberg J
J Urol; 2010 Jul; 184(1):352-7. PubMed ID: 20488477
[TBL] [Abstract][Full Text] [Related]
32. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology.
Kozlowski P; Chang SD; Jones EC; Berean KW; Chen H; Goldenberg SL
J Magn Reson Imaging; 2006 Jul; 24(1):108-13. PubMed ID: 16767709
[TBL] [Abstract][Full Text] [Related]
33. [Locoregional staging of prostatic carcinoma: accuracy of magnetic resonance with endorectal coil in 75 patients treated with radical prostatectomy].
Gualdi GF; Casciani E; Ferriano MG; Polettini E
Radiol Med; 1998 May; 95(5):498-505. PubMed ID: 9687928
[TBL] [Abstract][Full Text] [Related]
34. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
[TBL] [Abstract][Full Text] [Related]
35. [Laser treatment of benign prostatic hypertrophy: the correlation of histologic results to nuclear magnetic resonance imaging].
Sulser T; Jochum W; Huch Böni RA; Briner J; Krestin GP; Hauri D
Ann Urol (Paris); 1997; 31(1):19-26. PubMed ID: 9157818
[TBL] [Abstract][Full Text] [Related]
36. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
[TBL] [Abstract][Full Text] [Related]
37. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.
Nicoli N; Casaril A; Marchiori L; Mangiante G; Marini G; Colombari R; Portuese A; Hasheminia AR
Chir Ital; 2000; 52(1):29-40. PubMed ID: 10832524
[TBL] [Abstract][Full Text] [Related]
38. Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure.
Miralbell R; Vees H; Lozano J; Khan H; Mollà M; Hidalgo A; Linero D; Rouzaud M
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):356-61. PubMed ID: 17236961
[TBL] [Abstract][Full Text] [Related]
39. Diffusion tensor magnetic resonance imaging of prostate cancer.
Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
[TBL] [Abstract][Full Text] [Related]
40. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.
Wefer AE; Hricak H; Vigneron DB; Coakley FV; Lu Y; Wefer J; Mueller-Lisse U; Carroll PR; Kurhanewicz J
J Urol; 2000 Aug; 164(2):400-4. PubMed ID: 10893595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
